nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP2B6—Methimazole—Graves' disease	0.447	0.515	CbGbCtD
Clobazam—CYP2C19—Methimazole—Graves' disease	0.284	0.327	CbGbCtD
Clobazam—CYP3A4—Methimazole—Graves' disease	0.137	0.158	CbGbCtD
Clobazam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.0074	0.099	CbGpPWpGaD
Clobazam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00677	0.0905	CbGpPWpGaD
Clobazam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00592	0.0791	CbGpPWpGaD
Clobazam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00453	0.0606	CbGpPWpGaD
Clobazam—SLC6A11—eye—Graves' disease	0.00423	0.484	CbGeAlD
Clobazam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00415	0.0554	CbGpPWpGaD
Clobazam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00362	0.0484	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00305	0.0407	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00246	0.0328	CbGpPWpGaD
Clobazam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.00241	0.0322	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—GABRA3—Graves' disease	0.00233	0.0312	CbGpPWpGaD
Clobazam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.0022	0.0294	CbGpPWpGaD
Clobazam—Drowsiness—Methimazole—Graves' disease	0.00219	0.0712	CcSEcCtD
Clobazam—SLC6A1—Monoamine Transport—IL1B—Graves' disease	0.00209	0.0279	CbGpPWpGaD
Clobazam—SLC6A1—eye—Graves' disease	0.00198	0.227	CbGeAlD
Clobazam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.00192	0.0257	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—GABRA3—Graves' disease	0.00188	0.0252	CbGpPWpGaD
Clobazam—Drowsiness—Propylthiouracil—Graves' disease	0.00186	0.0606	CcSEcCtD
Clobazam—Chlordiazepoxide—GABRA3—Graves' disease	0.00162	0.0948	CrCbGaD
Clobazam—Leukopenia—Methimazole—Graves' disease	0.00153	0.0498	CcSEcCtD
Clobazam—Clorazepate—GABRA3—Graves' disease	0.00152	0.0887	CrCbGaD
Clobazam—SLC6A1—Monoamine Transport—TNF—Graves' disease	0.00152	0.0203	CbGpPWpGaD
Clobazam—SLC6A1—pituitary gland—Graves' disease	0.00147	0.168	CbGeAlD
Clobazam—Myalgia—Methimazole—Graves' disease	0.00146	0.0474	CcSEcCtD
Clobazam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.0014	0.0188	CbGpPWpGaD
Clobazam—Alprazolam—GABRA3—Graves' disease	0.00137	0.0803	CrCbGaD
Clobazam—Thrombocytopenia—Methimazole—Graves' disease	0.00137	0.0445	CcSEcCtD
Clobazam—Leukopenia—Propylthiouracil—Graves' disease	0.0013	0.0424	CcSEcCtD
Clobazam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.00128	0.0172	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00127	0.0414	CcSEcCtD
Clobazam—Flunitrazepam—GABRA3—Graves' disease	0.00126	0.0735	CrCbGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00126	0.0168	CbGpPWpGaD
Clobazam—Somnolence—Methimazole—Graves' disease	0.00124	0.0404	CcSEcCtD
Clobazam—Myalgia—Propylthiouracil—Graves' disease	0.00124	0.0403	CcSEcCtD
Clobazam—Estazolam—GABRA3—Graves' disease	0.00118	0.0688	CrCbGaD
Clobazam—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00116	0.0378	CcSEcCtD
Clobazam—Halazepam—GABRA3—Graves' disease	0.00114	0.0668	CrCbGaD
Clobazam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.00112	0.015	CbGpPWpGaD
Clobazam—Adinazolam—GABRA3—Graves' disease	0.00112	0.0655	CrCbGaD
Clobazam—Fludiazepam—GABRA3—Graves' disease	0.00111	0.0648	CrCbGaD
Clobazam—Urticaria—Methimazole—Graves' disease	0.00111	0.0361	CcSEcCtD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00111	0.0148	CbGpPWpGaD
Clobazam—Body temperature increased—Methimazole—Graves' disease	0.0011	0.0359	CcSEcCtD
Clobazam—Prazepam—GABRA3—Graves' disease	0.00108	0.0633	CrCbGaD
Clobazam—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00108	0.0352	CcSEcCtD
Clobazam—Somnolence—Propylthiouracil—Graves' disease	0.00105	0.0343	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00101	0.0135	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00101	0.0135	CbGpPWpGaD
Clobazam—Flurazepam—GABRA3—Graves' disease	0.00101	0.059	CrCbGaD
Clobazam—Triazolam—GABRA3—Graves' disease	0.00101	0.0589	CrCbGaD
Clobazam—Pruritus—Methimazole—Graves' disease	0.000987	0.0321	CcSEcCtD
Clobazam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000984	0.0132	CbGpPWpGaD
Clobazam—Oxazepam—GABRA3—Graves' disease	0.000977	0.0572	CrCbGaD
Clobazam—Temazepam—GABRA3—Graves' disease	0.000965	0.0564	CrCbGaD
Clobazam—Urticaria—Propylthiouracil—Graves' disease	0.000942	0.0307	CcSEcCtD
Clobazam—Body temperature increased—Propylthiouracil—Graves' disease	0.000938	0.0305	CcSEcCtD
Clobazam—Midazolam—GABRA3—Graves' disease	0.000936	0.0547	CrCbGaD
Clobazam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.0009	0.012	CbGpPWpGaD
Clobazam—Vomiting—Methimazole—Graves' disease	0.000887	0.0289	CcSEcCtD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000884	0.0118	CbGpPWpGaD
Clobazam—Rash—Methimazole—Graves' disease	0.00088	0.0286	CcSEcCtD
Clobazam—Dermatitis—Methimazole—Graves' disease	0.000879	0.0286	CcSEcCtD
Clobazam—Headache—Methimazole—Graves' disease	0.000874	0.0285	CcSEcCtD
Clobazam—Pruritus—Propylthiouracil—Graves' disease	0.000839	0.0273	CcSEcCtD
Clobazam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000831	0.0111	CbGpPWpGaD
Clobazam—Nausea—Methimazole—Graves' disease	0.000829	0.027	CcSEcCtD
Clobazam—Diazepam—GABRA3—Graves' disease	0.000802	0.0469	CrCbGaD
Clobazam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000787	0.0105	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00076	0.0102	CbGpPWpGaD
Clobazam—Vomiting—Propylthiouracil—Graves' disease	0.000754	0.0246	CcSEcCtD
Clobazam—Rash—Propylthiouracil—Graves' disease	0.000748	0.0244	CcSEcCtD
Clobazam—Dermatitis—Propylthiouracil—Graves' disease	0.000747	0.0243	CcSEcCtD
Clobazam—Headache—Propylthiouracil—Graves' disease	0.000743	0.0242	CcSEcCtD
Clobazam—Nausea—Propylthiouracil—Graves' disease	0.000705	0.0229	CcSEcCtD
Clobazam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000665	0.00888	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000637	0.00851	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—GC—Graves' disease	0.000632	0.00845	CbGpPWpGaD
Clobazam—GABRG2—pituitary gland—Graves' disease	0.000585	0.067	CbGeAlD
Clobazam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000583	0.00779	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000509	0.00681	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—B3GNT2—Graves' disease	0.000479	0.00641	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.00035	0.00468	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000342	0.00458	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000342	0.00458	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000337	0.00451	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000313	0.00419	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000278	0.00371	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000274	0.00366	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.00025	0.00334	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000244	0.00326	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000235	0.00314	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000234	0.00313	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.000231	0.00309	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000211	0.00282	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GC—Graves' disease	0.000191	0.00255	CbGpPWpGaD
Clobazam—ABCB1—pituitary gland—Graves' disease	0.000163	0.0187	CbGeAlD
Clobazam—ABCB1—adipose tissue—Graves' disease	0.000162	0.0186	CbGeAlD
Clobazam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000159	0.00213	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000159	0.00213	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000154	0.00206	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—B3GNT2—Graves' disease	0.000145	0.00193	CbGpPWpGaD
Clobazam—ABCB1—thyroid gland—Graves' disease	0.00014	0.0161	CbGeAlD
Clobazam—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000138	0.00184	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000137	0.00184	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00012	0.00161	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000116	0.00155	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000116	0.00154	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TNF—Graves' disease	9.98e-05	0.00133	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GC—Graves' disease	9.38e-05	0.00125	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—B3GNT2—Graves' disease	7.11e-05	0.00095	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GC—Graves' disease	7.09e-05	0.000948	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GC—Graves' disease	6.92e-05	0.000925	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—B3GNT2—Graves' disease	5.37e-05	0.000718	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—B3GNT2—Graves' disease	5.24e-05	0.000701	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	4.93e-05	0.000659	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GC—Graves' disease	4.26e-05	0.00057	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—B3GNT2—Graves' disease	3.23e-05	0.000432	CbGpPWpGaD
